Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
European Journal of Cancer2022Vol. 181, pp. 26–37
Citations Over TimeTop 10% of 2022 papers
Ye Guo, Weijie Zhang, Jieer Ying, Yanqiao Zhang, Yueyin Pan, Wensheng Qiu, Qingxia Fan, Qi Xu, Yue Ma, Gang Wang, Jing Guo, Weiguo Su, Songhua Fan, Panfeng Tan, Yan Wang, Yang Luo, Hui Zhou, Jin Li
Related Papers
- → Antibiotic de-escalation in the ICU(2015)57 cited
- → Dynamics of Violence: Processes of Escalation and De‐Escalation in Violent Group Conflicts(2002)5 cited
- → DOP51 De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation(2021)
- → Modelling Intergroup Conflict Escalation and De-Escalation(2010)